Fatty Liver Foundation
The voice of #FattyLiver, #NAFLD & #NASH. The only patient organization aimed at improving screening, education & outreach dedicated to fatty liver patients.
Integrating the Patient Voice in MASH Drug Development: PEDDLE’s New Standard of Engagement
The Bigger Picture: Insights and Support from the Steatotic Liver Disease (SLD) Community
Steatotic Liver disease (SLD) in the time of the Ozempic Revolution and GLP Treatment
Framing Liver Health for Success
Understanding Alcohol-associated Liver Disease
The Wellness League Search Tool - How to Find Clinical Studies
Getting to Know The Wellness League's Search Tool
Patients Leading the Way: How PEDDLE is Shaping the Future of MASH Trials
Unheard Voices: What the 2024 Fatty Liver Survey Tells Us About the Patient Journey
The Wellness League Search Tool How-To Guide
Unlocking the Future of Fatty Liver Risk Assessment: Introducing FLF’s AI-Driven Tool
Decoding the New Nomenclature: What SLD, MASLD, MASH, MetALD Mean for Patients and Providers
Understanding the New NAFLD/NASH Nomenclature: A Guide for Patients and Advocates
Helpful or Hurtful? The Future of AI in Healthcare
The Wellness League: An Ecosystem of Patient Support - AASLD 2022
Diana - NAFLD in Hispanics Latinos in the US - GoFundMe
Overall GoFundMe Video
The Genetics of NAFLD/NASH
The Other Pandemic: NAFLD/NASH A Major Neglected Global Public Health Problem
FDA Patient Panel - Terri's Contribution
FDA Patient Panel - Wayne's Contribution
Wellness Webinar Series | Part-Three (Wellness and Living with NAFLD/NASH: Patient Panel)
Wellness Webinar Series | Part-Two (Non-Invasive Tests for Diagnosis and Monitoring)
Non-invasive Screening and Genomics in NAFLD with Sano Genetics
Reviving Fatty Livers (CGTN Feature)
Wellness Webinar Series | Part-One (COVID-19 Vaccines and Liver Disease)
Fatty Liver Foundation and Madrigal Pharmaceuticals Webconference (Part 2: Advice for New Patients)